Korean Operations of Institute Pasteur, Sanofi-Aventis Partner to Screen for HBV Drugs

Nov 03, 2011

NEW YORK (GenomeWeb News) – The Korean operations of Institut Pasteur and Sanofi-Aventis announced on Wednesday a collaboration to screen for new compounds directed at Hepatitis B.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

French Funding Agency Head Resigns

The president of France's National Research Agency has resigned, according to Nature News.

Right to Try Versus Clinical Trials

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.